AlphaStocks

HRMY vs INCY

As of Sep 20, 2026, Harmony Biosciences Holdings (HRMY) scores 7.5/10 and Incyte (INCY) 7.5/10 on AlphaStocks' five-model composite, the same score. INCY trades 36% below its model fair value.

HRMY

Harmony Biosciences Holdings, Inc.

7.5

Strong Buy

$42.06

INCY

INCYTE CORP

7.5

Strong Buy

$125.31

HRMY vs INCY: Which is the Better Investment?

Harmony Biosciences Holdings, Inc. (HRMY) scores 7.5/10 while INCYTE CORP (INCY) scores 7.5/10 on AlphaStocks' composite model. Both stocks share the same composite score. On a P/E basis, Harmony Biosciences Holdings, Inc. trades at 15.5x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricHRMYINCY
Scores & Fundamentals
Composite Score7.5/107.5/10
RatingStrong BuyStrong Buy
Price$42.06$125.31
P/E Ratio15.519.6
ROE18.6%26.0%
Market Cap$2B$26B
Fair Value$195.21
Dividend Yield
Sector Rank#5 of 168#3 of 168
Model Verdicts
PiotroskiAttractiveStrong
BuffettAttractiveStrong
GrahamNeutralNeutral
LynchStrongNeutral
GreenblattStrongAttractive
View full HRMYanalysis →View full INCYanalysis →

Related comparisons

Compare any two stocks →

HRMY vs INCY: Which Stock Scores Higher?

Harmony Biosciences Holdings, Inc. (HRMY) and INCYTE CORP (INCY) are both in the Health Care sector. Both stocks are closely matched with composite scores of 7.5/10.

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer